HC Wainwright upgraded shares of FibroGen (NASDAQ:FGEN – Free Report) to a strong-buy rating in a report issued on Tuesday,Zacks.com reports. HC Wainwright also issued estimates for FibroGen’s Q4 2024 ...
Our research team assigns Silver ratings to strategies that they have a high conviction will outperform the relevant index, or most peers, over a market cycle on a risk-adjusted basis. Wymer ...
American Funds’ parent Capital Group announced that veteran manager Donald O’Neal will step off American Funds Growth Fund of America and retire from the firm on Jan. 1, 2025. O’Neal has ...
The following is a summary of “Dermal cellular senescence and EndMT in patients with systemic sclerosis undergoing cyclophosphamide or aHSCT treatment,” published in the December 2024 issue of ...